高级检索
lncRNA HAND2-AS1 Regulates Prostate Cancer Cell Growth Through Targeting the miR-106a-5p/RBM24 Axis

    作者

    Wei, PT; Yang, J; Zhang, DD; Cui, M; Li, LJ

    作者单位

    [Wei, Pengtao] Zhengzhou Univ, Luoyang Cent Hosp, Dept Urol, Luoyang 471000, Peoples R China; [Yang, Jing] Shandong Univ, Shandong Prov Hosp, Cent Sterile Supply Dept, Jinan, Peoples R China; [Zhang, Dandan] YiDu Cent Hosp Weifang City, Urinary Surg, Qingzhou, Peoples R China; [Cui, Meng] Shandong Prov Matern & Childcare Hosp, Dept Gynecol, Jinan, Peoples R China; [Li, Lianjun] Shandong Univ, Dept Urol, Shandong Prov Hosp, Jinan 250014, Peoples R China; [Li, Lianjun] Shandong First Med Univ, Shandong Prov Hosp, Dept Urol, Jinan 250014, Peoples R China

    摘要

    Introduction: Increasing evidence has shown that abnormally expressed long non-coding RNA (lncRNA) plays crucial roles in prostate cancer (PCa) progression. Materials and Methods: Here, we analyzed the expression level of lncRNA HAND2 antisense RNA 1 (HAND2-AS1) in PCa cells and tissues. Function assays were performed to investigate the biological roles of HAND2-AS1 in PCa cell behaviors. Bioinformatics methods, luciferase activity reporter assay, and RNA pull-down assay were performed to validate the connection of microRNA-106a-5p (miR-106a-5p) with HAND2-AS1. Also, the target of miR-106a-5p was explored using the same methods. Results: Our results revealed HAND2-AS1 expression was decreased in both PCa cells and tissues. In vitro functional assays showed HAND2-AS1 could inhibit PCa cell proliferation and colony formation through promoting cell apoptosis. Dual-luciferase activity assays showed miR-106a-5p could directly bind with HAND2-AS1 and RNA binding motif protein 24 (RBM24). Mechanistically, we showed that HAND2-AS1 regulates PCa cell behaviors via targeting miR-106a-5p/RBM24 axis. Conclusion: In summary, our results illustrated that HAND2-AS1 functions as miR-106a-5p sponge to regulate RBM24 expression, and to influence PCa progression.

    关键词

基本信息

  • 所属机构:

    归属医师: 杨静 李连军

    PMID:32547083

    UT:000534222800001

    刊名:ONCOTARGETS AND THERAPY

    年,卷(期):2020年13卷

    页码:4523-4531

    DOI:10.2147/OTT.S246274

    附件: other

    收录:   SCIE